Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colistin Inhalation for Ventilator Associated Pneumonia
NCT03622450Phase 3Completed
- Start
- Jan 2016
- Primary completion
- Jan 2018
- Modality
- Peptides
01
Overview
Phase 3, randomised, open-label trial of colistin in ventilator-associated pneumonia (VAP) (2 arms). Primary endpoint: Assessment of Ventilatory status. Started Jan 2016; status: completed.
02
Drugs
colistin
03
Conditions
ventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on NCT03622450.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03622450.